Characteristics of adults with influenza A virus pneumonia and co-infections identified by mNGS in Jilin, China during 2024–2025

Wei Li, Xin Di, Xiaohong Jiao, Lin Zhang, Jinyan YuFrontiers in Cellular and Infection Microbiology 2025 · DOI

TL;DR

This study demonstrates that metagenomic next-generation sequencing (mNGS) is significantly more sensitive than traditional throat swab PCR for diagnosing Influenza A (IAV) and its associated co-infections. In a cohort of 73 hospitalized patients, nearly 86% had secondary bacterial or fungal infections, highlighting that severe flu is rarely a "solo" viral performance.

What Problem Does This Paper Address?

Influenza A virus (IAV) remains a top-tier global health threat due to its pandemic potential and high mortality rates. However, clinicians face a "diagnostic gap": standard reverse transcription-PCR (RT-PCR) tests of throat swabs often return false negatives due to low viral loads in the upper respiratory tract or because the presence of other microbes "masks" the virus.

Furthermore, most flu-related deaths aren't caused by the virus alone, but by secondary bacterial or fungal pneumonia. Identifying these "hitchhiker" pathogens quickly is critical for choosing the right antibiotics or antifungals, yet traditional culturing methods are often too slow or insensitive to guide early treatment.

Methods

The researchers conducted a retrospective study of 73 adults hospitalized with IAV pneumonia in Jilin, China, between late 2024 and early 2025. They categorized patients into two groups based on disease severity: Mild-to-Moderate (MM) and Severe-to-Critical (SC).

The core technological approach was metagenomic next-generation sequencing (mNGS) performed on sputum or bronchoalveolar lavage fluid (BALF). Unlike traditional tests that look for a specific "target" (like a single gene), mNGS sequences all the genetic material in a clinical sample and compares it against massive databases of known pathogens. This allows for the simultaneous detection of viruses, bacteria, and fungi in a single run.

Datasets

The study utilized a primary clinical dataset of 73 hospitalized patients from The Second Hospital of Jilin University. For the mNGS bioinformatics pipeline, the researchers utilized standard reference databases, including NCBI nt and GenBank, alongside an in-house curated genomic database to identify microbial species.

Key Insights and Ideas

  • mNGS is the New Gold Standard for Sensitivity: The study found that while throat swab nucleic acid tests only caught 60% of IAV cases, mNGS had a 100% detection rate. This suggests that many "flu-like" illnesses missed by standard swabs are actually IAV residing deeper in the lungs.
  • Co-infection is the Rule, Not the Exception: A staggering 86.3% of patients had secondary infections. Bacterial infections were more prevalent in severe cases (86% in the SC group vs. 58% in the MM group).
  • The H3N2 and Airway Disease "Double Whammy": While H1N1 was the most common subtype overall, infection with the H3N2 subtype and underlying chronic airway diseases (like Asthma or COPD) were independent risk factors for progressing to critical illness.
  • Fungal Infections are Underestimated: Fungal co-infections (primarily Aspergillus and Candida) were found in 63% of the total cohort. Crucially, these occurred regardless of whether the patient had traditional comorbidities, suggesting IAV itself creates a pulmonary environment highly permissive to fungal growth.
  • Biomarkers of Severity: High D-dimer levels (indicating blood clotting issues) and low lymphocyte counts were strong predictors of severe disease, likely reflecting the "cytokine storm" and immune exhaustion caused by the viral-bacterial-fungal onslaught.

Key Results

  • Sensitivity Gap: mNGS (100%) vs. Throat Swab PCR (60%).
  • Pathogen Profile: H1N1 was found in 97% of cases, while H3N2 was found in 60% (often as a co-infection).
  • Bacterial Culprits: Streptococcus pneumoniae was the most common gram-positive bacterium, while Klebsiella pneumoniae was the most frequent gram-negative threat in severe cases.
  • Fungal Prevalence: Aspergillus was the most common fungal pathogen identified across both groups.
  • Clinical Outcomes: Patients in the severe (SC) group had significantly higher respiratory rates (27.4 vs 18.3 breaths/min) and higher levels of lactate dehydrogenase (LDH), a marker of tissue damage.

Limitations and Future Work

The authors acknowledge several limitations:

  1. Single-Center Study: The data comes from one hospital in Jilin, so the results might not perfectly represent other regions or different flu seasons.
  2. Sample Size: With only 73 patients, the statistical power for some sub-analyses is limited.
  3. The "Colonization" Problem: mNGS is so sensitive that it can detect "colonizing" bacteria—microbes that are present but not necessarily causing the disease. Distinguishing a true pathogen from a harmless resident remains a challenge.
  4. Future Directions: The authors suggest that future research should focus on larger, multi-center cohorts and explore the use of anticoagulant therapy (to address high D-dimer levels) as part of the clinical management of severe IAV pneumonia.

Summary updated

Abstract

mNGS is a sensitive method for detecting IAV co-infections, effectively identifying co-infection with pathogenic bacterial strains. Hospitalized patients with IAV pneumonia, especially those with H3N2 infection and chronic airway disease, showed a high prevalence of severe and critical illness [total: 8 [11%], severe/critical: 7 [25%]). Fungal infections were frequent regardless of the presence of underlying comorbidities, and patients with SC disease were more likely to develop gram-negative bacterial and fungal infections. These findings may assist clinicians in the early identification of critically ill patients and the provision of appropriate empirical treatment.
BibTeX
@inproceedings{li2025characteristics,
  author = {Wei Li and Xin Di and Xiaohong Jiao and Lin Zhang and Jinyan Yu},
  title = {{Characteristics of adults with influenza A virus pneumonia and co-infections identified by mNGS in Jilin, China during 2024–2025}},
  booktitle = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1662422},
}
Figure